These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 11573848)

  • 1. Olanzapine-induced rhabdomyolysis.
    Rosebraugh CJ; Flockhart DA; Yasuda SU; Woosley RL
    Ann Pharmacother; 2001 Sep; 35(9):1020-3. PubMed ID: 11573848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroleptic malignant syndrome in an adolescent receiving olanzapine-lithium combination therapy.
    Berry N; Pradhan S; Sagar R; Gupta SK
    Pharmacotherapy; 2003 Feb; 23(2):255-9. PubMed ID: 12587815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Olanzapine and rhabdomyolysis.
    Shuster J
    Nursing; 2000 Sep; 30(9):87. PubMed ID: 11022553
    [No Abstract]   [Full Text] [Related]  

  • 4. Marked elevation of serum creatine kinase associated with olanzapine therapy.
    Marcus EL; Vass A; Zislin J
    Ann Pharmacother; 1999 Jun; 33(6):697-700. PubMed ID: 10410183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatal status epilepticus associated with olanzapine therapy.
    Wyderski RJ; Starrett WG; Abou-Saif A
    Ann Pharmacother; 1999; 33(7-8):787-9. PubMed ID: 10466904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rhabdomyolysis reported for children and adolescents treated with antipsychotic medicines: a case series analysis.
    Star K; Iessa N; Almandil NB; Wilton L; Curran S; Edwards IR; Wong IC
    J Child Adolesc Psychopharmacol; 2012 Dec; 22(6):440-51. PubMed ID: 23234587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroleptic malignant syndrome associated with olanzapine.
    Filice GA; McDougall BC; Ercan-Fang N; Billington CJ
    Ann Pharmacother; 1998 Nov; 32(11):1158-9. PubMed ID: 9825080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Olanzapine-induced acute pancreatitis.
    Doucette DE; Grenier JP; Robertson PS
    Ann Pharmacother; 2000 Oct; 34(10):1128-31. PubMed ID: 11054978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Olanzapine induced rhabdomyolysis and serum creatine kinase increase].
    Ribeyron S; Guy C; Koenig M; Cathébras P
    Rev Med Interne; 2009 Jun; 30(6):477-85. PubMed ID: 19307047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effective treatment of depressive disorder with psychotic symptoms by olanzapine combination therapy].
    Schmitt A; Braus DF
    Dtsch Med Wochenschr; 2000 Dec; 125(50):1526-9. PubMed ID: 11190762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psoriasis during therapy with olanzapine.
    Latini A; Carducci M
    Eur J Dermatol; 2003; 13(4):404-5. PubMed ID: 12948926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pustular eruption induced by olanzapine, a novel antipsychotic agent.
    Adams BB; Mutasim DF
    J Am Acad Dermatol; 1999 Nov; 41(5 Pt 2):851-3. PubMed ID: 10534668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gluteal muscle damage and rhabdomyolysis after olanzapine poisoning: a case report.
    Yu G; Cui S; Jian T; Sun C; Shi L; Li Y; Kan B; Jian X
    J Int Med Res; 2021 Oct; 49(10):3000605211047761. PubMed ID: 34605302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetic ketoacidosis associated with olanzapine in an adolescent patient.
    Selva KA; Scott SM
    J Pediatr; 2001 Jun; 138(6):936-8. PubMed ID: 11391346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Olanzapine-induced glucose dysregulation.
    Bettinger TL; Mendelson SC; Dorson PG; Crismon ML
    Ann Pharmacother; 2000; 34(7-8):865-7. PubMed ID: 10928397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Olanzapine-induced diabetes mellitus.
    Bonanno DG; Davydov L; Botts SR
    Ann Pharmacother; 2001 May; 35(5):563-5. PubMed ID: 11346063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neuroleptic malignant syndrome after treatment with olanzapine].
    Emborg C
    Ugeskr Laeger; 1999 Mar; 161(10):1424-5. PubMed ID: 10085753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Olanzapine-induced diabetic ketoacidosis.
    Ragucci KR; Wells BJ
    Ann Pharmacother; 2001 Dec; 35(12):1556-8. PubMed ID: 11793618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Olanzapine-induced hyperventilation: case report.
    Sattar SP; Gastfriend DR
    J Psychiatry Neurosci; 2002 Sep; 27(5):360-3. PubMed ID: 12271791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Life threatening neuroleptic malignant syndrome due to olanzapine].
    Kopf A; Köster J; Schulz A; Krömker H; Becker T
    Psychiatr Prax; 2003 Jul; 30(5):279-82. PubMed ID: 12872187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.